Guiling Li
Union Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Guiling Li as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 16:36 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07424664 · A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal CancerUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology · recruiting · Uterine Cervical Neoplasms, Recurrent; Uterine Cervical Neoplasms, Metastatic; Vulvar Neoplasms; Vaginal Neoplasms · principal investigator
- Ph3NCT07400536 · A Clinical Study on the Treatment of LACC With Cadonilimab Combined With Chemotherapy Followed by CCRTUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology · recruiting · Locally Advanced Cervical Carcinoma · principal investigator
- Ph1NCT05866354 · To Evaluate Pharmacokinetics of Tisotumab Vedotin in Chinese Subjects With Metastatic or Recurrent Solid MalignanciesZai Lab (Shanghai) Co., Ltd. · completed · Solid Malignancies · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 16:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 16:36 UTC. The ranking covers the 200 most relevant of 1047 PubMed records, and a shared surname and initials can bring in a namesake. All 1047 on PubMed
- Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak.Cancer Discov · 20201,183 citationsRCR 55.1
- 1,171 citationsRCR 43.0
- 581 citationsRCR 30.1
- Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial.Cancer Cell · 2022462 citationsRCR 28.6
- Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR).J Clin Oncol · 2022435 citationsRCR 35.8
- Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials.J Hepatol · 2020423 citationsRCR 19.8
- 414 citationsRCR 25.9
- 384 citationsRCR 22.8
- Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA.N Engl J Med · 2021329 citationsRCR 21.1
- Laparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: Five-Year Outcomes From the CLASS-01 Randomized Clinical Trial.JAMA Surg · 2022238 citationsRCR 22.8